12 Health Care Stocks Moving In Wednesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movement in Wednesday's intraday session. Vivos Therapeutics (VVOS) saw a massive increase of 312.8%, while BioVie (BIVI) faced a sharp decline of 61.9%. Other notable gainers include China Pharma Holding (CPHI), Altamira Therapeutics (CYTO), Envoy Medical (COCH), Biomea Fusion (BMEA), and vTv Therapeutics (VTVT). On the losing side, BiomX (PHGE), Eagle Pharmaceuticals (EGRX), Journey Medical (DERM), Biodexa Pharmaceuticals (BDRX), and Patterson Cos (PDCO) saw significant drops, with PDCO specifically reacting to its Q2 earnings report.
November 29, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Vivos Therapeutics stock surged 312.8% with a market cap of $21.6 million.
The substantial increase in VVOS's stock price indicates strong investor interest, which could lead to continued short-term momentum.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
BioVie shares dropped 61.9% with a market cap of $71.7 million.
The sharp decline in BIVI's stock price suggests negative sentiment or potentially disappointing news, which could pressure the stock in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Patterson Cos shares fell 15.39% to $26.59 after the Q2 earnings report, with a market cap of $2.5 billion.
The decline in PDCO's stock price following its Q2 earnings report suggests the market's reaction was negative, which could lead to further short-term downside.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100